Humacyte Inc (HUMA) USD0.0001 A

Sell:$1.43Buy:$1.44$0.06 (4.05%)

NASDAQ:1.26%
Market closed | Prices delayed by at least 15 minutes
Sell:$1.43
Buy:$1.44
Change:$0.06 (4.05%)
Market closed | Prices delayed by at least 15 minutes
Sell:$1.43
Buy:$1.44
Change:$0.06 (4.05%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Humacyte, Inc. is a commercial-stage biotechnology platform company. The Company is engaged in developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced tissue constructs, and organ systems designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a range of diseases, injuries, and chronic conditions. It is using its proprietary, scientific technology platform to engineer and manufacture acellular tissue engineered vessels (ATEVs). The Company is also in late-stage clinical trials targeting other vascular applications, including arteriovenous (AV) access for hemodialysis and peripheral artery disease (PAD). The Company is also engaged in the preclinical development of coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple cell and tissue applications.

Key people

Laura E. Niklason
President, Chief Executive Officer, Director
Dale A. Sander
Chief Financial Officer, Chief Corporate Development Officer, Treasurer
Heather Prichard
Chief Operating Officer
Yang Cao
Chief Regulatory Officer
Shamik J. Parikh
Chief Medical Officer
William Scheessele
Chief Commercial Officer
Kathleen Sebelius
Independent Chairman of the Board
John P Bamforth
Director
Brady W. Dougan
Director
Keith Anthony Jones
Director
Rajiv Sarman Shukla
Director
Click to see more

Key facts

  • EPIC
    HUMA
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US44486Q1031
  • Market cap
    $228.02m
  • Employees
    218
  • Shares in issue
    155.12m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.